CD44 and neoplasm: In ChS studies, researchers also identified high expression of CD44 (phagocytic glycoprotein 1, PGP-1)—a tumor stem cell marker, but also a lymphocyte homing receptor and a receptor for hyaluronan, osteopontin (OPN), collagens, and MMPs [33].